Actuate Therapeutics ACTU
NASDAQ ACTU
$0.30 +0.01 (+1.89%)
As of: Nov 11, 2026 · 1:30 PM EST

Actuate Therapeutics (ACTU) Other Non Operating Income (2023 - 2024)

Updated

Actuate Therapeutics (ACTU) recorded Other Non Operating Income of $78,903 in FY2024, down 1.2% from $79,822 in FY2023.

Analysis

Actuate Therapeutics (ACTU) Other Non Operating Income (2023 - 2024) Analysis & Trends

  • Per Business Quant data, ACTU's Other Non Operating Income was $79,822 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Actuate Therapeutics 7.20 Mn -35.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -193,951.00
Jun 30, 2024 240,339.00
Mar 31, 2024 32,515.00
Dec 31, 2023 51,598.00
Sep 30, 2023 -16,866.00
Jun 30, 2023 50,194.00
API Access

Actuate Therapeutics Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ACTU&period=max&api_key=YOUR_API_KEY